Response to Omalizumab in a Patient With Chronic Eosinophilic Pneumonia and Poor Response to Corticosteroids

被引：5
作者：
Lavina-Soriano, Eduardo [1 ]
Ampuero-Lopez, Ana [1 ]
Luis Izquierdo-Alonso, Jose [1 ]
机构：
[1] Hosp Univ Guadalajara, Serv Neumol, Guadalajara, Spain
来源：
ARCHIVOS DE BRONCONEUMOLOGIA | 2018年 / 54卷 / 07期
关键词：
FC-EPSILON-RI; ALLERGIC-ASTHMA; BASOPHILS; THERAPY;
D O I：
10.1016/j.arbres.2017.11.009
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：393 / 394
页数：2
相关论文
共 12 条
[1]   Omalizumab-induced reductions in mast cell FcεRI expression and function [J].
Beck, LA ;
Marcotte, GV ;
MacGlashan, D ;
Togias, A ;
Saini, S .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (03) :527-530
[2]   Anti-IgE therapy results in decreased myeloid dendritic cells in asthmatic airways [J].
Chand, Hitendra S. ;
Schuyler, Mark ;
Joste, Nancy ;
Hensler, Charlene ;
Tesfaigzi, Yohannes ;
Masten, Barbara ;
Schrader, Ron ;
Lipscomb, Mary F. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (05) :1157-1158
[3]   Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma [J].
Djukanovic, R ;
Wilson, SJ ;
Kraft, M ;
Jarjour, NN ;
Steel, M ;
Chung, KF ;
Bao, WB ;
Fowler-Taylor, A ;
Matthews, J ;
Busse, WW ;
Holgate, ST ;
Fahy, JV .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (06) :583-593
[4]  
Domingo C, 2013, CHEST, V143, P274, DOI 10.1378/chest.12-2035
[5]   Omalizumab as a Steroid-Sparing Agent in Chronic Eosinophilic Pneumonia [J].
Kaya, Hatice ;
Gumus, Seyfettin ;
Ucar, Ergun ;
Aydogan, Mehmet ;
Musabak, Ugur ;
Tozkoparan, Ergun ;
Bilgic, Hayati .
CHEST, 2012, 142 (02) :513-516
[6]   Bronchial Smooth Muscle Cells of Asthmatics Promote Angiogenesis through Elevated Secretion of CXC-Chemokines (ENA-78, GRO-α, and IL-8) [J].
Keglowich, Laura ;
Roth, Michael ;
Philippova, Maria ;
Resink, Therese ;
Tjin, Gavin ;
Oliver, Brian ;
Lardinois, Didier ;
Dessus-Babus, Sophie ;
Gosens, Reinoud ;
Haack, Katrin Hostettler ;
Tamm, Michael ;
Borger, Peter .
PLOS ONE, 2013, 8 (12)
[7]   Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils [J].
Lin, H ;
Boesel, KM ;
Prussin, C ;
Foster, B ;
Romero, FA ;
Townley, R ;
Casale, TB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (02) :297-302
[8]   Reduced FcεRI-Mediated Release of Asthma-Promoting Cytokines and Chemokines from Human Basophils during Omalizumab Therapy [J].
Oliver, Janet M. ;
Tarleton, Christy A. ;
Gilmartin, Laura ;
Archibeque, Tereassa ;
Qualls, Clifford R. ;
Diehl, Lorena ;
Wilson, Bridget S. ;
Schuyler, Mark .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2010, 151 (04) :275-284
[9]   Novel targets of omalizumab in asthma [J].
Sattler, Caroline ;
Garcia, Gilles ;
Humbert, Marc .
CURRENT OPINION IN PULMONARY MEDICINE, 2017, 23 (01) :56-61
[10]   Decreases in human dendritic cell-dependent TH2-like responses after acute in vivo IgE neutralization [J].
Schroeder, John T. ;
Bieneman, Anja P. ;
Chichester, Kristin L. ;
Hamilton, Robert G. ;
Xiao, HuiQing ;
Saini, Sarbjit S. ;
Liu, Mark C. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (04) :896-901
12